Telo Genomics Assessing MRD Status in TELO-DMRD Study – $TDSGF.US $TELO.V
Telo Genomics Assessing MRD Status in TELO-DMRD Study – $TDSGF.US $TELO.V
Blog
Read More
BioMark Diagnostics Completes Testing of over 5,400 Subjects as Part of a Validation Study for Early Lung Cancer Detection – $BMKDF.US $BUX.CN
BioMark Diagnostics Completes Testing of over 5,400 Subjects as Part of a Validation Study for Early Lung Cancer Detection – $BMKDF.US $BUX.CN
BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+™ for Prostate Cancer – $BCT.TO $BCTX.US $BCTXW.US
BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+™ for Prostate Cancer – $BCT.TO $BCTX.US $BCTXW.US
VitalHub Corp. Recognized Among Top Performers in the 2024 TSX30 Ranking – $VHI.TO $VHIBF.US
VitalHub Corp. Recognized Among Top Performers in the 2024 TSX30 Ranking – $VHI.TO $VHIBF.US
Perimeter Medical Imaging AI Announces Non-Brokered Private Placement – $PINK.V $PYNKF.US
Perimeter Medical Imaging AI Announces Non-Brokered Private Placement – $PINK.V $PYNKF.US
WELL Provides Corporate Update on Canadian Clinics Reflecting Strong Growth Momentum and Return on Invested Capital (ROIC) Performance – $WELL.TO $WHTCF.US
WELL Provides Corporate Update on Canadian Clinics Reflecting Strong Growth Momentum and Return on Invested Capital (ROIC) Performance – $WELL.TO $WHTCF.US
BioNxt Receives Positive International Examination Report From the European Patent Office for Broad Patent Application for Sublingual Delivery of Anticancer Drugs for the Treatment of Autoimmune Neurodegenerative Diseases – $BNXT.CN
BioNxt Receives Positive International Examination Report From the European Patent Office for Broad Patent Application for Sublingual Delivery of Anticancer Drugs for the Treatment of Autoimmune Neurodegenerative Diseases – $BNXT.CN
Ventripoint Issues Option Grants and Reports Exercise of Options – $VPT.V $VPTDF.US
Ventripoint Issues Option Grants and Reports Exercise of Options – $VPT.V $VPTDF.US
Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis – $QNTM.CN $QNTM.US
Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis – $QNTM.CN $QNTM.US
Revitalist Announces Strategic Partnership with Sama Therapeutics to Advance Digital Human AI Agents for Precision Mental Health – $CALM.CN $RVLWF.US
Revitalist Announces Strategic Partnership with Sama Therapeutics to Advance Digital Human AI Agents for Precision Mental Health – $CALM.CN $RVLWF.US